A new report from AARP Public Policy Institute found that the top 25 drugs prescribed under Medicare Part D have nearly ...
Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, ...
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...
A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual ...
Seniors on Medicare Part D will never pay more than $2,000 out-of-pocket for prescription drugs annually, thanks to a ...
Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...
Medicare enrollees will now pay a maximum of $2,000 on out-of-pocket prescription drug costs annually as part of another ...